ANXA1 and cancer: In this context, cancer cells are normally under higher stress levels than normal cells, leading to plasma membrane damage, so ANXA1 could be a promising adjuvant treatment combined with current oncologic treatments to prevent plasma membrane repair in cancer cells after anti-proliferative treatments.